The Gut–Brain–Immune Axis in Chronic Disease: Mechanisms and Therapeutic Opportunities — A Narrative Synthesis
Integrative Biomedical Research · 01.04.2026 · 10 (1) · 1-8
DOI: 10.25163/biomedical.10110884 ↗Kurz gefasst
Fachartikel in der Zeitschrift Integrative Biomedical Research, online erschienen am 01.04.2026.
Abstract (Originalsprache)
The gastrointestinal microbiota shapes host metabolism, immunity, and brain function through a tripartite gut–brain–immune axis, yet the field still lacks a unified synthesis linking barrier failure, immunometabolic signaling, and disease-specific outcomes. We conducted a structured narrative review of preclinical and clinical literature indexed largely through PubMed-listed sources, synthesizing evidence on neural, endocrine, immunological, and microbial-metabolite communication pathways and their dysregulation in Parkinson’s disease, Alzheimer’s disease, multiple sclerosis, and related chronic conditions. Across disorders, intestinal barrier failure and endotoxemia recur as a shared upstream trigger, converging on microglial activation, kynurenine pathway shunting toward neurotoxic quinolinic acid, and blood–brain barrier compromise, while each disease additionally shows a distinctive dysbiotic signature and cellular trafficking pattern—vagal alpha-synuclein propagation in Parkinson’s disease, amyloid cross-seeding in Alzheimer’s disease, and Th17-mediated demyelination in multiple sclerosis. Microbiome-directed interventions, including dietary modulation, psychobiotics, and fecal microbiota transplantation, showed measurable, if heterogeneous, benefit; a placebo-controlled fecal transplantation trial in Parkinson’s disease, for instance, reported meaningfully greater motor improvement than placebo. The evidence, taken together, supports the gut–brain–immune axis as a mechanistically coherent and therapeutically actionable framework, though translation remains constrained by engraftment variability and a scarcity of standardized, biomarker-guided trial designs. Personalized, multi-omics-informed strategies appear to be the most promising path toward clinical utility.
Zitieren
APA
(2026). The Gut–Brain–Immune Axis in Chronic Disease: Mechanisms and Therapeutic Opportunities — A Narrative Synthesis. Integrative Biomedical Research, 10(1), 1-8. https://doi.org/10.25163/biomedical.10110884
Vancouver
The Gut–Brain–Immune Axis in Chronic Disease: Mechanisms and Therapeutic Opportunities — A Narrative Synthesis. Integrative Biomedical Research. 2026;10(1):1-8. doi:10.25163/biomedical.10110884
BibTeX
@article{euvimed2026,
title = {The Gut–Brain–Immune Axis in Chronic Disease: Mechanisms and Therapeutic Opportunities — A Narrative Synthesis},
journal = {Integrative Biomedical Research},
year = {2026},
volume = {10},
number = {1},
pages = {1--8},
doi = {10.25163/biomedical.10110884}
}
EUVIMED